$10.50
-0.07-0.66%
At close: -
$12.90
2.4022.86%
After Hours: Apr 14, 4:59 PM EDT
Comments
Loading...
Cartesian Therapeutics Stock Price, Quotes and Forecasts
RNACNASDAQ
Cartesian Therapeutics (RNAC) Forecast
NewsEarningsCartesian Therapeutics (RNAC) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Cartesian Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:RNAC | Benzinga
Explore Cartesian Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for RNAC.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cartesian Therapeutics (RNAC) stock?
You can purchase shares of Cartesian Therapeutics (NASDAQ:RNAC) through any online brokerage.
Who are Cartesian Therapeutics (RNAC) competitors?
Other companies in Cartesian Therapeutics’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Humacyte (NASDAQ:HUMA), Altimmune (NASDAQ:ALT), aTyr Pharma (NASDAQ:ATYR) and Olema Pharmaceuticals (NASDAQ:OLMA).
What is the forecast, or price target, for Cartesian Therapeutics (RNAC) stock?
Cartesian Therapeutics has a consensus price target of $40.83.
What is the current price for Cartesian Therapeutics (RNAC)?
The stock price for Cartesian Therapeutics (NASDAQ: RNAC) is $12.9 last updated April 14, 2025 at 4:59 PM EDT.
Does Cartesian Therapeutics (RNAC) pay a dividend?
There are no upcoming dividends for Cartesian Therapeutics.
When is Cartesian Therapeutics (NASDAQ:RNAC) reporting earnings?
Cartesian Therapeutics’s Q1 earnings are confirmed for Wednesday, May 7, 2025.
Is Cartesian Therapeutics (RNAC) going to split?
There is no upcoming split for Cartesian Therapeutics.
What sector and industry does Cartesian Therapeutics (RNAC) operate in?
Cartesian Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
